Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overweight or Obese, Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07809568
What this trial is testing

Real-World Outcomes of Tirzepatide in Pakistani Adults With Obesity, Prediabetes, and Type 2 Diabetes

Who this might be right for
Prediabetes or OverweightObesity Type 2 Diabetes MellitusObesity & Overweight
Universiti Sains Malaysia 330
Large-scale testing (Phase 3)WithdrawnNCT00541567
What this trial is testing

BMS-646256 in Obese and Overweight Type 2 Diabetics

Who this might be right for
Obesity and Type 2 Diabetes
Solvay Pharmaceuticals 600
Early research (Phase 1)Study completedNCT05363774
What this trial is testing

A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.

Who this might be right for
Healthy Volunteers (Diabetes Mellitus, Type 2)
Novo Nordisk A/S 161
Testing effectiveness (Phase 2)Looking for participantsNCT07724340
What this trial is testing

Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity

Who this might be right for
Adults With Overweight/Obesity and Type 2 Diabetes
Antag Therapeutics 150
Early research (Phase 1)Looking for participantsNCT07747857
What this trial is testing

A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity

Who this might be right for
Type 2 Diabetes Mellitus Combined With Overweight or Obesity
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 72
Testing effectiveness (Phase 2)WithdrawnNCT06901349
What this trial is testing

Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes

Who this might be right for
ObesityOverweight
Eli Lilly and Company
Post-approval studies (Phase 4)Enrolling By InvitationNCT06845345
What this trial is testing

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Who this might be right for
Diabetes Mellitus, Type 2Liver FibrosisLiver Steatoses+9 more
Carmen Dietvorst 70
Large-scale testing (Phase 3)Looking for participantsNCT07667803
What this trial is testing

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

Who this might be right for
Weight Management
AstraZeneca 4,500
Not applicableUnknownNCT05908812
What this trial is testing

Relationship Between Glycemic Control and Irisin in Type 2 Diabetic Patients With Sarcopenic or Non-sarcopenic Obesity

Who this might be right for
SarcopeniaObesityDiabetes Mellitus, Type 2
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 120
Not applicableStudy completedNCT00458029
What this trial is testing

Middle-School Based Primary Prevention Trial of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 4,603
Testing effectiveness (Phase 2)Active Not RecruitingNCT06628362
What this trial is testing

Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

Who this might be right for
Overweight or ObeseType 2 Diabetes Mellitus (T2DM)
Carmot Therapeutics, Inc. 447
Large-scale testing (Phase 3)Looking for participantsNCT07392190
What this trial is testing

Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Who this might be right for
OverweightObesity
Eli Lilly and Company 900
Large-scale testing (Phase 3)Active Not RecruitingNCT07220759
What this trial is testing

Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide

Who this might be right for
OverweightObesityType 2 Diabetes
Novo Nordisk A/S 330
Large-scale testing (Phase 3)Study completedNCT00546325
What this trial is testing

REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 358
Large-scale testing (Phase 3)Active Not RecruitingNCT07357415
What this trial is testing

Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight

Who this might be right for
ObesityOverweight
Eli Lilly and Company 600
Large-scale testing (Phase 3)Ended earlyNCT00458081
What this trial is testing

Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors

Who this might be right for
ObesityMicroalbuminuriaDiabetes Mellitus, Type 2+1 more
Sanofi 174
Testing effectiveness (Phase 2)Study completedNCT06897202
What this trial is testing

Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

Who this might be right for
Obesity in DiabetesType 2 Diabetes Mellitus (T2DM)
Pfizer 133
Testing effectiveness (Phase 2)WithdrawnNCT06104358
What this trial is testing

Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes

Who this might be right for
Diabete Type 2Obesity
Rivus Pharmaceuticals, Inc.
Not applicableUnknownNCT01443143
What this trial is testing

Blood Glucose Stability and Variability on Two Diets

Who this might be right for
Type 2 DiabetesObesity
Nutrisystem, Inc. 15
Large-scale testing (Phase 3)Ended earlyNCT04741074
What this trial is testing

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy

Who this might be right for
CKDDiabetic Kidney DiseaseType 2 Diabetes Mellitus in Obese+2 more
Geisinger Clinic 15
Next Page